FeesSafety
Pluang+

Ripple USD leads 24-hour stablecoin market-cap growth with $128.6M increase

Market News
03 Nov 2026, 15:33 WIB
Tokenpost
View Source
Bullish
Ripple USD leads 24-hour stablecoin market-cap growth with $128.6M increase

Ripple USD (RLUSD) saw the largest 24-hour increase in stablecoin market capitalization, rising by $128.6 million. Over the past 90 days, RLUSD's market cap grew by $765.3 million, ranking it below Circle's $915 million gain but above United Stables' $474.2 million. RLUSD now accounts for 0.8% of the stablecoin supply, compared to Tether's dominant 61% share. Additionally, RLUSD added 23,600 new holder addresses in 90 days, placing it among the top 10 stablecoins for holder growth, signaling increasing adoption and interest in the token.

Ripple USD (RLUSD) leads stablecoin market-cap gains with a $128.6 million increase, ranking its 90-day market cap growth of $765.3 million between Circle's $915 million and United Stables' $474.2 million. For readers following cryptocurrency markets, here is Pluang's snapshot as of Nov 03, 2026 20:23 WIB: among 50 major cryptocurrencies, 19 rose and 30 fell today. Notably, EOS rose 8.13% to Rp12,649 with a typical hold time of 87 days, while CRV and BAT declined by 4.29% and 4.09% respectively, with BAT showing strong buy interest at 95%.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App